• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病保护突变 A2T 调节淀粉样蛋白-β(Aβ)聚集的动力学和热力学性质。

The Alzheimer disease protective mutation A2T modulates kinetic and thermodynamic properties of amyloid-β (Aβ) aggregation.

机构信息

From the VIB Center for the Biology of Disease, the Center for Human Genetics and Leuven Institute for Neurodegenerative Diseases, University of Leuven.

the VIB Switch Laboratory, the Switch Laboratory, Department of Cellular and Molecular Medicine.

出版信息

J Biol Chem. 2014 Nov 7;289(45):30977-89. doi: 10.1074/jbc.M114.599027. Epub 2014 Sep 24.

DOI:10.1074/jbc.M114.599027
PMID:25253695
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4223304/
Abstract

Missense mutations in alanine 673 of the amyloid precursor protein (APP), which corresponds to the second alanine of the amyloid β (Aβ) sequence, have dramatic impact on the risk for Alzheimer disease; A2V is causative, and A2T is protective. Assuming a crucial role of amyloid-Aβ in neurodegeneration, we hypothesized that both A2V and A2T mutations cause distinct changes in Aβ properties that may at least partially explain these completely different phenotypes. Using human APP-overexpressing primary neurons, we observed significantly decreased Aβ production in the A2T mutant along with an enhanced Aβ generation in the A2V mutant confirming earlier data from non-neuronal cell lines. More importantly, thioflavin T fluorescence assays revealed that the mutations, while having little effect on Aβ42 peptide aggregation, dramatically change the properties of the Aβ40 pool with A2V accelerating and A2T delaying aggregation of the Aβ peptides. In line with the kinetic data, Aβ A2T demonstrated an increase in the solubility at equilibrium, an effect that was also observed in all mixtures of the A2T mutant with the wild type Aβ40. We propose that in addition to the reduced β-secretase cleavage of APP, the impaired propensity to aggregate may be part of the protective effect conferred by A2T substitution. The interpretation of the protective effect of this mutation is thus much more complicated than proposed previously.

摘要

淀粉样前体蛋白(APP)中丙氨酸 673 的错义突变,与淀粉样 β(Aβ)序列的第二个丙氨酸相对应,对阿尔茨海默病的风险有巨大影响;A2V 是致病的,而 A2T 是保护性的。鉴于淀粉样蛋白-Aβ 在神经退行性变中的关键作用,我们假设 A2V 和 A2T 突变会导致 Aβ 性质的明显变化,这至少可以部分解释这两种完全不同的表型。使用人 APP 过表达原代神经元,我们观察到 A2T 突变体中 Aβ 生成显著减少,而 A2V 突变体中 Aβ 生成增强,这证实了先前来自非神经元细胞系的数据。更重要的是,硫黄素 T 荧光测定显示,这些突变对 Aβ42 肽聚集几乎没有影响,但极大地改变了 Aβ40 池的性质,A2V 加速了 Aβ 肽的聚集,而 A2T 则延缓了聚集。与动力学数据一致,Aβ A2T 在平衡时的溶解度增加,这种效应也在 A2T 突变体与野生型 Aβ40 的所有混合物中观察到。我们提出,除了 APP 的β-分泌酶切割减少之外,聚集倾向受损可能是 A2T 取代赋予保护作用的一部分。因此,对该突变的保护作用的解释比之前提出的要复杂得多。

相似文献

1
The Alzheimer disease protective mutation A2T modulates kinetic and thermodynamic properties of amyloid-β (Aβ) aggregation.阿尔茨海默病保护突变 A2T 调节淀粉样蛋白-β(Aβ)聚集的动力学和热力学性质。
J Biol Chem. 2014 Nov 7;289(45):30977-89. doi: 10.1074/jbc.M114.599027. Epub 2014 Sep 24.
2
Molecular mechanisms of Alzheimer disease protection by the A673T allele of amyloid precursor protein.淀粉样前体蛋白 A673T 等位基因对阿尔茨海默病的保护作用的分子机制。
J Biol Chem. 2014 Nov 7;289(45):30990-1000. doi: 10.1074/jbc.M114.589069. Epub 2014 Sep 24.
3
A2T and A2V Aβ peptides exhibit different aggregation kinetics, primary nucleation, morphology, structure, and LTP inhibition.A2T和A2Vβ淀粉样肽表现出不同的聚集动力学、初级成核、形态、结构以及对长时程增强的抑制作用。
Proteins. 2016 Apr;84(4):488-500. doi: 10.1002/prot.24995. Epub 2016 Feb 23.
4
Alzheimer's protective A2T mutation changes the conformational landscape of the Aβ₁₋₄₂ monomer differently than does the A2V mutation.阿尔茨海默病保护性A2T突变对Aβ₁₋₄₂单体构象态势的改变与A2V突变不同。
Biophys J. 2015 Feb 3;108(3):738-47. doi: 10.1016/j.bpj.2014.12.013.
5
Amyloid β-Protein Assembly: Differential Effects of the Protective A2T Mutation and Recessive A2V Familial Alzheimer's Disease Mutation.淀粉样β蛋白组装:保护性A2T突变和隐性A2V家族性阿尔茨海默病突变的不同影响。
ACS Chem Neurosci. 2015 Oct 21;6(10):1732-40. doi: 10.1021/acschemneuro.5b00171. Epub 2015 Aug 12.
6
Dimerization Mechanism of Alzheimer Aβ Peptides: The High Content of Intrapeptide-Stabilized Conformations in A2V and A2T Heterozygous Dimers Retards Amyloid Fibril Formation.阿尔茨海默病 Aβ 肽的二聚化机制:A2V 和 A2T 杂合二聚体中肽内稳定构象的高含量延缓淀粉样纤维形成。
J Phys Chem B. 2016 Dec 1;120(47):12111-12126. doi: 10.1021/acs.jpcb.6b10722. Epub 2016 Nov 16.
7
The A673T mutation in the amyloid precursor protein reduces the production of β-amyloid protein from its β-carboxyl terminal fragment in cells.淀粉样前体蛋白的 A673T 突变减少了细胞中β-淀粉样蛋白从其β-羧基末端片段的产生。
Acta Neuropathol Commun. 2015 Nov 4;3:66. doi: 10.1186/s40478-015-0247-6.
8
Alternative Selection of β-Site APP-Cleaving Enzyme 1 (BACE1) Cleavage Sites in Amyloid β-Protein Precursor (APP) Harboring Protective and Pathogenic Mutations within the Aβ Sequence.淀粉样β蛋白前体(APP)中β位点APP裂解酶1(BACE1)裂解位点的替代选择,该APP在Aβ序列内具有保护性和致病性突变。
J Biol Chem. 2016 Nov 11;291(46):24041-24053. doi: 10.1074/jbc.M116.744722. Epub 2016 Sep 29.
9
Familial Alzheimer's disease mutations in amyloid protein precursor alter proteolysis by γ-secretase to increase amyloid β-peptides of ≥45 residues.淀粉样蛋白前体中的家族性阿尔茨海默病突变通过 γ-分泌酶改变蛋白水解,从而增加≥45 个残基的淀粉样 β 肽。
J Biol Chem. 2021 Jan-Jun;296:100281. doi: 10.1016/j.jbc.2021.100281. Epub 2021 Jan 12.
10
The Pathogenic A2V Mutant Exhibits Distinct Aggregation Kinetics, Metal Site Structure, and Metal Exchange of the Cu -Aβ Complex.致病性A2V突变体表现出不同的聚集动力学、金属位点结构以及铜-Aβ复合物的金属交换。
Chemistry. 2017 Oct 4;23(55):13591-13595. doi: 10.1002/chem.201703440. Epub 2017 Sep 5.

引用本文的文献

1
β-Amyloids and Immune Responses Associated with Alzheimer's Disease.β-淀粉样蛋白与阿尔茨海默病相关的免疫反应。
Cells. 2024 Sep 28;13(19):1624. doi: 10.3390/cells13191624.
2
Transmissible long-term neuroprotective and pro-cognitive effects of 1-42 beta-amyloid with A2T icelandic mutation in an Alzheimer's disease mouse model.在阿尔茨海默病小鼠模型中,携带冰岛A2T突变的β-淀粉样蛋白1-42的可传播长期神经保护和促认知作用。
Mol Psychiatry. 2024 Dec;29(12):3707-3721. doi: 10.1038/s41380-024-02611-8. Epub 2024 Jun 14.
3
Can Genetic Markers Predict the Sporadic Form of Alzheimer's Disease? An Updated Review on Genetic Peripheral Markers.遗传标志物能否预测散发性阿尔茨海默病?遗传外周标志物的最新综述。
Int J Mol Sci. 2023 Aug 30;24(17):13480. doi: 10.3390/ijms241713480.
4
Unraveling Molecular and Genetic Insights into Neurodegenerative Diseases: Advances in Understanding Alzheimer's, Parkinson's, and Huntington's Diseases and Amyotrophic Lateral Sclerosis.揭示神经退行性疾病的分子和遗传见解:对阿尔茨海默病、帕金森病、亨廷顿病和肌萎缩侧索硬化症的理解的进展。
Int J Mol Sci. 2023 Jun 28;24(13):10809. doi: 10.3390/ijms241310809.
5
Aβ1-6(D) peptide, effective on Aβ aggregation, inhibits tau misfolding and protects the brain after traumatic brain injury.Aβ1-6(D) 肽能有效抑制 Aβ 聚集,防止 tau 错误折叠,并在创伤性脑损伤后保护大脑。
Mol Psychiatry. 2023 Jun;28(6):2433-2444. doi: 10.1038/s41380-023-02101-3. Epub 2023 May 17.
6
N-terminal Domain of Amyloid-β Impacts Fibrillation and Neurotoxicity.淀粉样β蛋白的N端结构域影响纤维化和神经毒性。
ACS Omega. 2022 Oct 18;7(43):38847-38855. doi: 10.1021/acsomega.2c04583. eCollection 2022 Nov 1.
7
A novel bio-inspired strategy to prevent amyloidogenesis and synaptic damage in Alzheimer's disease.一种新颖的仿生策略,可预防阿尔茨海默病中的淀粉样蛋白形成和突触损伤。
Mol Psychiatry. 2022 Dec;27(12):5227-5234. doi: 10.1038/s41380-022-01745-x. Epub 2022 Aug 26.
8
Resolution exchange with tunneling for enhanced sampling of protein landscapes.分辨率交换与隧道效应增强蛋白质构象采样。
Phys Rev E. 2022 Jul;106(1-2):015302. doi: 10.1103/PhysRevE.106.015302.
9
Exploring the Involvement of the Amyloid Precursor Protein A673T Mutation against Amyloid Pathology and Alzheimer's Disease in Relation to Therapeutic Editing Tools.探索淀粉样前体蛋白A673T突变与淀粉样病理及阿尔茨海默病的关系以及相关治疗编辑工具的作用。
Pharmaceutics. 2022 Jun 15;14(6):1270. doi: 10.3390/pharmaceutics14061270.
10
AAV-mediated delivery of an anti-BACE1 VHH alleviates pathology in an Alzheimer's disease model.AAV 介导的抗 BACE1 VHH 递呈缓解阿尔茨海默病模型中的病理。
EMBO Mol Med. 2022 Apr 7;14(4):e09824. doi: 10.15252/emmm.201809824. Epub 2022 Mar 30.

本文引用的文献

1
Pathways to Alzheimer's disease.阿尔茨海默病的发病途径。
J Intern Med. 2014 Mar;275(3):296-303. doi: 10.1111/joim.12192.
2
A mutation protective against Alzheimer's disease renders amyloid β precursor protein incapable of mediating neurotoxicity.一种能抵抗阿尔茨海默病的突变使淀粉样β前体蛋白无法介导神经毒性。
J Neurochem. 2014 Jul;130(2):291-300. doi: 10.1111/jnc.12717. Epub 2014 Apr 10.
3
On the subject of rigor in the study of amyloid β-protein assembly.关于淀粉样β蛋白组装研究中的严谨性问题。
Alzheimers Res Ther. 2013 Aug 27;5(4):39. doi: 10.1186/alzrt203. eCollection 2013.
4
FcγRIIb mediates amyloid-β neurotoxicity and memory impairment in Alzheimer's disease.FcγRIIb 在阿尔茨海默病中介导淀粉样β 神经毒性和记忆损伤。
J Clin Invest. 2013 Jul;123(7):2791-802. doi: 10.1172/JCI66827. Epub 2013 Jun 10.
5
Amyloid-β protofibrils: size, morphology and synaptotoxicity of an engineered mimic.淀粉样β原纤维:工程模拟物的大小、形态和突触毒性。
PLoS One. 2013 Jul 2;8(7):e66101. doi: 10.1371/journal.pone.0066101. Print 2013.
6
Alzheimer's disease risk alleles in TREM2 illuminate innate immunity in Alzheimer's disease.TREM2 中的阿尔茨海默病风险等位基因阐明了阿尔茨海默病中的固有免疫。
Alzheimers Res Ther. 2013 May 21;5(3):24. doi: 10.1186/alzrt178. eCollection 2013.
7
Bapineuzumab captures the N-terminus of the Alzheimer's disease amyloid-beta peptide in a helical conformation.巴喷丁结合阿尔茨海默病淀粉样β肽的 N 端以螺旋构象存在。
Sci Rep. 2013;3:1302. doi: 10.1038/srep01302.
8
Early accumulation of intracellular fibrillar oligomers and late congophilic amyloid angiopathy in mice expressing the Osaka intra-Aβ APP mutation.在表达 Osaka 内 Aβ APP 突变的小鼠中,细胞内纤维状寡聚物的早期积累和晚期亲刚果红淀粉样血管病。
Transl Psychiatry. 2012 Nov 13;2(11):e183. doi: 10.1038/tp.2012.109.
9
Amyloid precursor protein (APP) A673T mutation in the elderly Finnish population.老年芬兰人群中的淀粉样前体蛋白(APP)A673T 突变。
Neurobiol Aging. 2013 May;34(5):1518.e1-3. doi: 10.1016/j.neurobiolaging.2012.09.017. Epub 2012 Oct 24.
10
Molecular plasticity regulates oligomerization and cytotoxicity of the multipeptide-length amyloid-β peptide pool.分子可塑性调节多肽长度淀粉样β肽池的寡聚化和细胞毒性。
J Biol Chem. 2012 Oct 26;287(44):36732-43. doi: 10.1074/jbc.M112.394635. Epub 2012 Sep 19.